Logo image of SYPR

SYPRIS SOLUTIONS INC (SYPR) Stock Fundamental Analysis

NASDAQ:SYPR - Nasdaq - US8716551069 - Common Stock - Currency: USD

1.95  +0.01 (+0.52%)

Fundamental Rating

2

Overall SYPR gets a fundamental rating of 2 out of 10. We evaluated SYPR against 81 industry peers in the Automobile Components industry. SYPR has a bad profitability rating. Also its financial health evaluation is rather negative. SYPR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

SYPR had negative earnings in the past year.
In the past year SYPR has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: SYPR reported negative net income in multiple years.
Of the past 5 years SYPR 4 years had a positive operating cash flow.
SYPR Yearly Net Income VS EBIT VS OCF VS FCFSYPR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

1.2 Ratios

SYPR has a Return On Assets of -2.34%. This is in the lower half of the industry: SYPR underperforms 77.78% of its industry peers.
With a Return On Equity value of -13.59%, SYPR is not doing good in the industry: 79.01% of the companies in the same industry are doing better.
SYPR has a worse Return On Invested Capital (5.36%) than 72.84% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SYPR is significantly below the industry average of 9.04%.
The last Return On Invested Capital (5.36%) for SYPR is above the 3 year average (2.72%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -2.34%
ROE -13.59%
ROIC 5.36%
ROA(3y)-1.68%
ROA(5y)0.28%
ROE(3y)-9.48%
ROE(5y)-0.39%
ROIC(3y)2.72%
ROIC(5y)2.33%
SYPR Yearly ROA, ROE, ROICSYPR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

The Operating Margin of SYPR (1.65%) is worse than 81.48% of its industry peers.
SYPR's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 13.71%, SYPR is doing worse than 81.48% of the companies in the same industry.
SYPR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.65%
PM (TTM) N/A
GM 13.71%
OM growth 3Y2.29%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.59%
GM growth 5Y4.73%
SYPR Yearly Profit, Operating, Gross MarginsSYPR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SYPR is destroying value.
The number of shares outstanding for SYPR has been increased compared to 1 year ago.
SYPR has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, SYPR has a worse debt to assets ratio.
SYPR Yearly Shares OutstandingSYPR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
SYPR Yearly Total Debt VS Total AssetsSYPR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

SYPR has an Altman-Z score of 0.62. This is a bad value and indicates that SYPR is not financially healthy and even has some risk of bankruptcy.
SYPR has a Altman-Z score of 0.62. This is amonst the worse of the industry: SYPR underperforms 90.12% of its industry peers.
SYPR has a Debt/Equity ratio of 0.73. This is a neutral value indicating SYPR is somewhat dependend on debt financing.
SYPR has a worse Debt to Equity ratio (0.73) than 76.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF N/A
Altman-Z 0.62
ROIC/WACC0.61
WACC8.74%
SYPR Yearly LT Debt VS Equity VS FCFSYPR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

SYPR has a Current Ratio of 1.29. This is a normal value and indicates that SYPR is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.29, SYPR is not doing good in the industry: 88.89% of the companies in the same industry are doing better.
SYPR has a Quick Ratio of 1.29. This is a bad value and indicates that SYPR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.39, SYPR is not doing good in the industry: 95.06% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 0.39
SYPR Yearly Current Assets VS Current LiabilitesSYPR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

3

3. Growth

3.1 Past

SYPR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.96%, which is quite impressive.
The Revenue has grown by 21.65% in the past year. This is a very strong growth!
The Revenue has been growing by 9.78% on average over the past years. This is quite good.
EPS 1Y (TTM)30.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%59.84%
Revenue 1Y (TTM)21.65%
Revenue growth 3Y12.9%
Revenue growth 5Y9.78%
Sales Q2Q%-17%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SYPR Yearly Revenue VS EstimatesSYPR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
SYPR Yearly EPS VS EstimatesSYPR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2017 2018 2019 0 -0.5 -1 -1.5

0

4. Valuation

4.1 Price/Earnings Ratio

SYPR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SYPR Price Earnings VS Forward Price EarningsSYPR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SYPR is valued a bit more expensive than the industry average as 62.96% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.1
SYPR Per share dataSYPR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

SYPR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SYPRIS SOLUTIONS INC

NASDAQ:SYPR (6/3/2025, 8:00:00 PM)

1.95

+0.01 (+0.52%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)05-20 2025-05-20
Earnings (Next)08-11 2025-08-11
Inst Owners17.38%
Inst Owner Change0.37%
Ins Owners30.68%
Ins Owner Change-0.32%
Market Cap44.81M
Analysts43.33
Price TargetN/A
Short Float %3.79%
Short Ratio20.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.26
P/FCF N/A
P/OCF N/A
P/B 2.36
P/tB 2.36
EV/EBITDA 9.1
EPS(TTM)-0.12
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS7.38
BVpS0.83
TBVpS0.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.34%
ROE -13.59%
ROCE 6.87%
ROIC 5.36%
ROICexc 6.39%
ROICexgc 6.39%
OM 1.65%
PM (TTM) N/A
GM 13.71%
FCFM N/A
ROA(3y)-1.68%
ROA(5y)0.28%
ROE(3y)-9.48%
ROE(5y)-0.39%
ROIC(3y)2.72%
ROIC(5y)2.33%
ROICexc(3y)3.63%
ROICexc(5y)3.12%
ROICexgc(3y)3.63%
ROICexgc(5y)3.12%
ROCE(3y)3.48%
ROCE(5y)2.97%
ROICexcg growth 3Y19.32%
ROICexcg growth 5YN/A
ROICexc growth 3Y19.32%
ROICexc growth 5YN/A
OM growth 3Y2.29%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.59%
GM growth 5Y4.73%
F-Score5
Asset Turnover1.54
Health
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF N/A
Debt/EBITDA 2.36
Cap/Depr 25.37%
Cap/Sales 0.45%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 0.39
Altman-Z 0.62
F-Score5
WACC8.74%
ROIC/WACC0.61
Cap/Depr(3y)66.02%
Cap/Depr(5y)73.22%
Cap/Sales(3y)1.7%
Cap/Sales(5y)1.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%59.84%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)21.65%
Revenue growth 3Y12.9%
Revenue growth 5Y9.78%
Sales Q2Q%-17%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y469.49%
EBIT growth 3Y15.49%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-120.01%
FCF growth 3Y-13.44%
FCF growth 5YN/A
OCF growth 1Y-111.52%
OCF growth 3Y-22.1%
OCF growth 5YN/A